Rephonic
Artwork for CCO Oncology Podcast

CCO Oncology Podcast

Clinical Care Options
Chronic Lymphocytic Leukemia
BTK Inhibitors
Non-Small Cell Lung Cancer
Mantle Cell Lymphoma
Her3-Targeted Therapy
CAR T-Cell Therapy
Clinical Trials
Triangle Study
Pyrtobrutinib
SHINE Trial
NCCN Guidelines
ASCO Annual Meeting
AML Treatment Regimens
Acute Myelogenous Leukemia
Small Lymphocytic Lymphoma
Gold Standard Therapy
Myelofibrosis
Palliative Care
Oral Sirds
Oral Chemotherapy

Updates on new data and best practices in the care of patients with cancer across a wide variety of solid tumors and hematologic malignancies from Clinical Care Options. Gain practical clinical insights and strategies and earn CME/CE credit for selected episodes.

PublishesTwice weeklyEpisodes215Founded5 years ago
Number of ListenersCategories
Health & FitnessCoursesMedicineEducation

Listen to this Podcast

Artwork for CCO Oncology Podcast

Latest Episodes

In this episode, Dr Rachel Grisham and Dr Kathleen Moore discuss newly approved treatments for low-grade serous ovarian cancer (LGSOC) and how recent research has transformed the therapeutic landscape for these patients, including:

• Molecular disti... more

YouTube

In this episode, Kathleen N. Moore, MD, MS, FASCO, and Isabelle Ray-Coquard, MD, PhD, discuss the emerging role of CDH6-targeting antibody–drug conjugates (ADCs) for ovarian cancer, including:

• Results of the phase I trial of raludotatug deruxtecan... more

YouTube

In this podcast, Dr David Miller, MD, PhD, FAAD and Dr Vishal Patel, MD discuss the evolving treatment landscape and immunotherapeutic strategies for cutaneous squamous cell carcinoma (cSCC) based on key data from pivotal studies that are reshaping s... more

YouTube

In this educational podcast discussion, Carlos M. De Castro, MD, and David Dingli, MD, PhD, FRCP, FRCPEd, FACP, FRCPath, explore paroxysmal nocturnal hemoglobinuria (PNH). They trace the evolution of treatment from early complement inhibitors to toda... more

YouTube

Key Facts

Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc Docs
Two Onc DocsSam and Karine
The ONS Podcast
The ONS PodcastOncology Nursing Society
AFP: American Family Physician Podcast
AFP: American Family Physician PodcastAmerican Academy of Family Physicians
The Curbsiders Internal Medicine Podcast
The Curbsiders Internal Medicine PodcastThe Curbsiders Internal Medicine Podcast
NEJM This Week
NEJM This WeekNEJM Group

Recent Guests

Amit Mahipal
Director of the Gastrointestinal Medical Oncology Program and Professor of Medicine
Case Western Reserve University
Episode: HER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancers: Testing Recommendations and New Treatment Options
Shubham Pant
Professor of GI Medical Oncology and Director of Clinical Research at MD Anderson Cancer Center
MD Anderson Cancer Center
Episode: HER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancers: Testing Recommendations and New Treatment Options
Dr. Kelly Romo
Healthcare professional specializing in oncology at Blue Cross and Blue Shield of Michigan.
Blue Cross and Blue Shield of Michigan
Episode: Available and Emerging Subcutaneous Immunotherapy Treatment Options for Patients With Cancer: A Pharmacy Perspective
Dr. Shauna Kraft
Pharmacist and academic at the University of Michigan College of Pharmacy.
University of Michigan
Episode: Available and Emerging Subcutaneous Immunotherapy Treatment Options for Patients With Cancer: A Pharmacy Perspective
Eunice Wang
Oncologist from Roswell Park
Roswell Park Comprehensive Cancer Center
Episode: A New Revolution in AML Treatment: Can Menin Inhibitors Follow the Path of FLT3 and IDH Inhibitors?
Eytan Stein
Oncologist
Episode: A New Revolution in AML Treatment: Can Menin Inhibitors Follow the Path of FLT3 and IDH Inhibitors?
Joseph Franses
Assistant professor of medicine at the University of Chicago in the section of Hematology-Oncology.
University of Chicago
Episode: Incorporating Immune Checkpoint Inhibitors Across the Disease Spectrum of Hepatocellular Carcinoma
Neehar Parikh
Associate professor in the Division of Gastroenterology & Hepatology at the University of Michigan.
University of Michigan
Episode: Incorporating Immune Checkpoint Inhibitors Across the Disease Spectrum of Hepatocellular Carcinoma
Mark Yarchoan
Associate Professor of Medical Oncology at the Sidney Kimmel Cancer Institute at Johns Hopkins University.
Johns Hopkins University
Episode: Incorporating Immune Checkpoint Inhibitors Across the Disease Spectrum of Hepatocellular Carcinoma

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Apple Podcasts
#66
Germany/Education/Courses
Apple Podcasts
#234
Italy/Education/Courses
Apple Podcasts
#22
Argentina/Education/Courses
Apple Podcasts
#50
Sweden/Education/Courses
Apple Podcasts
#53
Japan/Education/Courses
Apple Podcasts
#54
Singapore/Education/Courses
Apple Podcasts
#67
Netherlands/Education/Courses
Apple Podcasts
#68
United Arab Emirates/Education/Courses
Apple Podcasts
#72
Chile/Education/Courses
Apple Podcasts
#72
South Korea/Education/Courses
Apple Podcasts
#79
South Africa/Education/Courses
Apple Podcasts
#109
India/Education/Courses
Apple Podcasts
#122
Denmark/Education/Courses
Apple Podcasts
#143
Hong Kong/Education/Courses
Apple Podcasts
#153
Austria/Education/Courses
Apple Podcasts
#178
Taiwan/Education/Courses
Apple Podcasts
#182
Israel/Education/Courses
Apple Podcasts
#193
Norway/Education/Courses
Apple Podcasts
#207
Argentina/Education
Apple Podcasts
#235
New Zealand/Education/Courses

Talking Points

Recent interactions between the hosts and their guests.

Advancing the Care of Patients With HR-Positive/HER2-Negative Metastatic Breast Cancer
Q: If a patient is not tolerating one of the CDK46 inhibitors, what does your approach look like?
If there's no evidence of disease progression, I prefer switching to an alternative CDK46 inhibitor instead of moving on to the next line of treatment.
Advancing the Care of Patients With HR-Positive/HER2-Negative Metastatic Breast Cancer
Q: What are some of the clinical or treatment-related outcomes that you're looking at that guide the decision for which CDK46 inhibitor to use?
The decision involves considering overall survival benefits, side effect profiles, and the patient's expressed goals for treatment.
Current Considerations for Adverse Event Management With HER3-Directed Agents
Q: What is one thing that you would like community practitioners to know about HER3-targeted therapy?
There is currently no HER3-targeted therapy or ADC that is approved, but it's an exciting time with new drugs showing promising efficacy signals.
Expert Insight on Seminal New Clinical Trial Data Presented at the 2023 IGCS Conference Informing Treatment for Endometrial, Ovarian, and Cervical Cancers
Q: What are you going to do in your practice with the cervical cancer data?
Dr. Fujiwara indicated he would likely use the interlaced regimen, probably in combination with PEMBRO, once the A18 result is approved for regulatory agents.
Expert Insight on Seminal New Clinical Trial Data Presented at the 2023 IGCS Conference Informing Treatment for Endometrial, Ovarian, and Cervical Cancers
Q: How do you apply these results in your practice?
Dr. Slomovitz suggests that it's early to incorporate the new data based on Dervalumab and Tesolizumab, but acknowledges that both Pembrolizumab and Dostarlumab are active agents and can be interchangeable in practice.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About CCO Oncology Podcast

What is CCO Oncology Podcast about and what kind of topics does it cover?

This series focuses on the latest developments in cancer treatment and patient care, offering insights from leading experts in the field. Episodes tackle a wide range of topics, from emerging therapies and clinical trial results to practical strategies for managing patient care across various cancer types, including both solid tumors and hematologic malignancies. The conversations not only highlight current research but also emphasize the importance of personalized approaches in cancer therapy, patient education, and evolving treatment paradigms. Special attention is given to developments in areas like bispecific antibodies, immunotherapy, and treatment options tailored to specific cancer types, providing listeners with valuable information... more

Where can I find podcast stats for CCO Oncology Podcast?

Rephonic provides a wide range of podcast stats for CCO Oncology Podcast. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to CCO Oncology Podcast and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does CCO Oncology Podcast get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for CCO Oncology Podcast, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for CCO Oncology Podcast?

Rephonic provides comprehensive predictive audience data for CCO Oncology Podcast, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does CCO Oncology Podcast have?

To see how many followers or subscribers CCO Oncology Podcast has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to CCO Oncology Podcast?

These podcasts share a similar audience with CCO Oncology Podcast:

1. Two Onc Docs
2. The ONS Podcast
3. AFP: American Family Physician Podcast
4. The Curbsiders Internal Medicine Podcast
5. NEJM This Week

How many episodes of CCO Oncology Podcast are there?

CCO Oncology Podcast launched 5 years ago and published 215 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact CCO Oncology Podcast?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for CCO Oncology Podcast?

Rephonic pulls ratings and reviews for CCO Oncology Podcast from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for CCO Oncology Podcast?

Rephonic provides full transcripts for episodes of CCO Oncology Podcast. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on CCO Oncology Podcast?

Recent guests on CCO Oncology Podcast include:

1. Amit Mahipal
2. Shubham Pant
3. Dr. Kelly Romo
4. Dr. Shauna Kraft
5. Eunice Wang
6. Eytan Stein
7. Joseph Franses
8. Neehar Parikh

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days